From Harry Johns <[email protected]>
Subject Your 'Yes' could offer #MoreTime
Date May 6, 2021 12:07 PM
  Links have been removed from this email. Learn more in the FAQ.
  Links have been removed from this email. Learn more in the FAQ.
Your 'YES' today could give people with Alzheimer's and their families more memorable days.

Alzheimer's Association

[link removed]

Dear John,

We must act together now to have our voices heard.

[link removed]

More than six million Americans are estimated to have Alzheimer's today, and everyone who has the disease will die of it or with it. There are no survivors. A treatment for
Alzheimer's disease has not been approved since 2003. Those treatments that are approved only improve symptoms, and only for some. Not one stops or slows progression of the disease.

That could, and should, soon change. The U.S. Food and Drug Administration (FDA) is currently reviewing aducanumab, a new treatment for Alzheimer's. A clinical trial of aducanumab reported a 22% reduction in cognitive and functional decline compared to placebo.

It's time for more time for those facing Alzheimer's.

[link removed]

John, if an Alzheimer's treatment could provide more good days with your loved ones would you want it?

[link removed]

YES

[link removed]

Patients facing terminal cancers and other fatal diseases have benefited from approvals of treatments that offer them and their families more time. Those facing Alzheimer's deserve the same opportunity.

[link removed]

This treatment could add weeks, months or even years for individuals and families. Today, simply by clicking 'YES',you could help gain #MoreTime.

[link removed]

Can we count on you?

Will you say 'YES' to the potential for #MoreTime for those impacted by Alzheimer's?

[link removed]

Sincerely,
Harry Johns
President/CEO
Alzheimer's Association

P.S. Now is the time for #MoreTime. For more information visit, alz.org/moretime.

[link removed]

Disclosures

The author, who is an employee of the Alzheimer's
Association, has no individual disclosures. The Alzheimer's
Association received 0.89% of its total 2020 contributed revenue from
the biotechnology, pharmaceutical, diagnostics and clinical research
industry, including 0.15% from Biogen and Eisai. alz.org/transparency

[link removed]

Alzheimer's Association Home Office, 225 N. Michigan Ave., Fl. 17,
Chicago, IL 60601

© Alzheimer's Association. All rights reserved.
800.272.3900 | alz.org

[link removed]

® | Donate

[link removed]

Please add [email protected] to your address book to ensure you receive
all future emails.
 
Having trouble reading this email?
View it in your browser
[link removed]
 
View your email preferences or unsubscribe.
[link removed]


To unsubscribe from all future email, paste the following URL into your browser:
[link removed]
Screenshot of the email generated on import

Message Analysis